SCOPUS 정보 검색 플랫폼

American Journal of Ophthalmology

Volumn 140, Issue 6, 2005, Pages 1136-1139

Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma

(3) Blasi, Maria Antonietta a,c Giammaria, Daniele a Balestrazzi, Emilio b

a UNIVERSITY OF L'AQUILA (Italy)

b CATHOLIC UNIVERSITY (Italy)

c SAN SALVATORE HOSPITAL (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

AGED; ARTICLE; BASAL CELL CARCINOMA; BURNING SENSATION; CANCER IMMUNOTHERAPY; CASE REPORT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; ERYTHEMA; EYELID CARCINOMA; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; PUNCTATE KERATITIS; SKIN MANIFESTATION; SLIT LAMP; TUMOR RECURRENCE; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, TOPICAL; AGED, 80 AND OVER; AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; CARCINOMA, BASAL CELL; EYELID NEOPLASMS; FEMALE; HUMANS; IMMUNOTHERAPY; INTERFERON INDUCERS; MALE; OINTMENTS; TREATMENT OUTCOME;

EID: 29244483927 PISSN: 00029394 EISSN: None Source Type: Journal
DOI: 10.1016/j.ajo.2005.06.057 Document Type: Article

Times cited : (38)

References (7)

1
- 12944270573
- Epidemiologic characteristics and clinical course of patients with malignant eyelid tumours in an incidence cohort in Olmstead County, Minnesota
- B.E. Cook, G.B. Bartley Epidemiologic characteristics and clinical course of patients with malignant eyelid tumours in an incidence cohort in Olmstead County, Minnesota Ophthalmology 106 1999 746 750
- (1999) Ophthalmology , vol.106 , pp. 746-750
- Cook, B.E.¹ Bartley, G.B.²

2
- 1842581342
- The Australian Mohs database, part II. Periocular basal cell carcinoma outcome at 5-year follow-up
- R. Malhotra, S.C. Huilgol, N.T. Huynh, D. Selva The Australian Mohs database, part II. Periocular basal cell carcinoma outcome at 5-year follow-up Ophthalmology 111 2004 631 636
- (2004) Ophthalmology , vol.111 , pp. 631-636
- Malhotra, R.¹ Huilgol, S.C.² Huynh, N.T.³ Selva, D.⁴

3
- 0032694077
- Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream
- K.R. Beutner, J.K. Geisse, D. Helman Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream J Am Acad Dermatol 41 1999 1002 1007
- (1999) J Am Acad Dermatol , vol.41 , pp. 1002-1007
- Beutner, K.R.¹ Geisse, J.K.² Helman, D.³

4
- 0036715342
- Efficacy of topical imiquimod 5% cream for the treatment of nodular basal cell carcinoma: Comparison of dosage regimens
- S. Shumack, J. Robinson, S. Kossard Efficacy of topical imiquimod 5% cream for the treatment of nodular basal cell carcinoma comparison of dosage regimens Arch Dermatol 138 2002 1165 1171
- (2002) Arch Dermatol , vol.138 , pp. 1165-1171
- Shumack, S.¹ Robinson, J.² Kossard, S.³

5
- 1942504386
- Topical imiquimod treatment for nodular basal cell carcinomas: An open-label series
- A. Huber, J.D. Huber, R.B.J. Skinner Topical imiquimod treatment for nodular basal cell carcinomas an open-label series Dermatol Surg 30 2004 429 430
- (2004) Dermatol Surg , vol.30 , pp. 429-430
- Huber, A.¹ Huber, J.D.² Skinner, R.B.J.³

6
- 0036008014
- Small antiviral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway
- H. Hemmi, T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo, K. Hoshino Small antiviral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway Nat Immunol 3 2002 196 200
- (2002) Nat Immunol , vol.3 , pp. 196-200
- Hemmi, H.¹ Kaisho, T.² Takeuchi, O.³ Sato, S.⁴ Sanjo, H.⁵ Hoshino, K.⁶

7
- 0032619393
- Imiquimod applied topically: A novel immune response modifier and new class of drug
- R.L. Miller, J.F. Gerster, M.L. Owens, H.B. Slade, M.A. Toami Imiquimod applied topically a novel immune response modifier and new class of drug Int J Immunopharmacol 21 1999 1 14.s
- (1999) Int J Immunopharmacol , vol.21
- Miller, R.L.¹ Gerster, J.F.² Owens, M.L.³ Slade, H.B.⁴ Toami, M.A.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.